Request More Information Contact the Seller

  • RE:  Two-Location Independent Pharmacy Platform - South
  • Contact:  Tyler Le

Quick Facts

Asking Price: $11,500,000
Annual Revenue: $9,951,000
Net Profit: Not Disclosed
Cash Flow: $2,167,000
Total Debt: Not Disclosed
FF&E: Not Disclosed
Real Estate: Not Disclosed
Year Established: 2018
Employees: 13
BBN Listing #: 1015878
Broker Reference #: 60373-710291

Email or Print Listing

Business Overview:

Highly profitable two-location independent retail pharmacy operating in Orange County and San Bernardino County, California. TTM revenue of $9.95M with $2.17M Adjusted EBITDA (21.8% margin) — independently validated by Plante & Moran, PLLC, a top-15 U.S. CPA firm, as part of a formal Quality of Earnings review. +37% YoY Adjusted EBITDA growth.

Both locations are INSIDE medical office buildings — 6 of the top 10 prescribers practice in the SAME building as our pharmacies. Regional hospital is steps away with shared parking (Orange County). Modern VPN-enabled technology stack for multi-store and enterprise management (Leading PMS, Parata robotic dispensing, 2D barcode scanning). Business has implemented an AI Automation bot to process prescriptions 24/7 at a fraction of the labor cost. Owner is not active in day-to-day operations; both Pharmacists-in-Charge are long-tenured and highly likely to remain post-close.

Growth catalysts in flight: drive-through expansion under construction at one location (permits pulled, ground broken), 470+ ALF beds in advanced LTC pipeline discussions, Medicare Part B DMEPOS billing infrastructure and Medicare Part B Mass Immunizer active.

Transaction: Structured as a Stock Sale (negotiable) at $11,500,000 listed. Real estate leased at both locations (assumable). 1–6 month flexible transition. Full Plante & Moran QoE workbook released post-IOI.

Contact the Seller:

To request more information regarding this listing, simply check the ADD TO REQUEST INFO BASKET button (above Quick Facts) and when you are done searching and have made all your selections, simply click on the REQUEST FREE INFO button at the bottom of this page.

Property Features and Assets:

* Entity: California S-Corporation, 100% owned by a single owner.

* Location 1 (2018): San Bernardino County opened on the ground floor of a 3-story medical office building.

* Location 2 (2022): Orange County — opened on the ground floor of a 7-story medical office building; Regional hospital is steps away with shared parking.

* Operating Model: Decentralized — each site has its own Pharmacist-in-Charge and team, sharing back-office systems (accounting, payroll, wholesaler, PSAO) connected via VPN.

* Current Initiative: 3-license platform expansion underway (new Drive-Thru retail flagship adds a 3rd pharmacy license; existing pharmacies remain comboshops with dual NPI/NCPDP for retail + LTC). This new location will share the building with an urgent care and primary care physician office.

* Transaction Structure: Stock Sale (negotiable).

Market Competition and Expansion:

* Chain Retreat Creates Demand: CVS, Walgreens, and Rite Aid have closed 2,000+ U.S. stores since 2023. Well-positioned independents are recapturing displaced demand — particularly in the medical-office-embedded submarkets these pharmacies occupy.

* Physician-Adjacency Moat: 6 of top 10 prescribers practice in the SAME building as our pharmacies — geographic, sticky, and expensive to replicate in the same submarket.

*Third-Party QoE (Plante & Moran): QoE-validated financials are rare at this size — materially strengthens buyer confidence and compresses diligence time.

*Modern Multi-Store Tech Stack: Leading PMS, Parata robotic dispensing, 2D barcode scanning — designed for multi-store enterprise management, VPN-enabled across sites, and includes VOPIX and shared PBX phone system integrated with PMS for click to call, fax, and ability to use vendor apps in case of power outage.

* AI Automation Bot: 24/7 automated Rx processing at a fraction of human tech labor cost — differentiated cost structure in an industry where labor is the largest opex line.

* Growing LTC Market: Southern California ALF bed supply is growing faster than LTC pharmacy capacity. Dedicated LTC license pivot addresses undersupplied demand.

* 3-License Expansion / Drive-Through Flagship: New drive-through retail flagship location under construction — permits pulled, ground broken. Buyer inherits committed CapEx. This new location will share the building with an urgent care and primary care physician office.

* LTC Pipeline (470+ Beds): 470+ ALF beds in advanced discussion — to be serviced by existing comboshop operations (both locations carry dual NPI/NCPDP for retail + LTC). Additionally, currently servicing 4 LTC facilities .

* AI Automation Bots — Multi-Site Rollout: Bots deployed at both locations and very scalable. Both locations will be able to expand volume without any additional staff.

* Medicare Part B DMEPOS: Diabetic Supplies (855-S) approved at one location; Immunizations (855-B) active at both sites. Additional DMEPOS categories available.

* Additional Levers: MTM, RPM, 340B contract pharmacy (with nearby FQHC), expanded immunization outreach, compounding (greenfield), and structured B2B delivery — all documented, none activated.

Reason for Selling:

Focus on other business. Kindly ask the seller for more information.

Additional Details:

  • The property is Leased.
  • The owner is willing to train/assist the new owner.
  • This is not homebased business opportunity.
  • This is not a franchise resale opportunity

Relevant Links:

Request More Information

BusinessBroker.net is one of the largest business for sale marketplaces in the world that connects tens-of-thousands of business buyers and sellers every month. Sell a Business Online or if you’re a broker or a commercial agent sign up for a Business Broker Membership today!

    Add Businesses and/or Franchises
    To Basket For Free Information

    This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our cookies information for more details.